Abstract

Sinapic acid (SA) modulates the nuclear factor-erythroid 2-related factor 2 (Nrf2) signaling pathway in chondrocytes. In order to test the hypothesis that SA is protective against the development of osteoarthritis (OA), primary mouse chondrocytes were treated in vitro with SA and the promoter transactivation activity of heme oxygenase 1 (HO-1), nuclear translocation of Nrf2, and protein expression of HO-1 were assayed. To test the hypothesis in vivo, a destabilization of the medial meniscus (DMM) model was used to induce OA in the knees of mice and SA was delivered orally to the experimental group. The chondrocytes were harvested for further analysis. The expression of HO-1 was similarly upregulated in cartilage from both the experimental mice and human chondrocytes from osteoarthritic knees. SA was found to enhance the promoter transactivation activity of heme oxygenase 1 (HO-1) and increase the expression of Nrf2 and HO-1 in primary chondrocytes. Histopathologic scores showed that the damage induced by the DMM model was significantly lower in the SA treatment group. The addition of a HO-1 inhibitor with SA did not show additional benefit over SA alone in terms of cartilage degradation or histopathologic scores. The expression of TNF-α, IL-1β, IL-6, MMP-1, MMP-3, MMP-13, ADAMTS4, and ADAMTS5 was significantly reduced both in vitro and in vivo by the presence of SA. Protein expressions of HO-1 and Nrf2 were substantially increased in knee cartilage of mice that received oral SA. Our results suggest that SA should be further explored as a preventative treatment for OA.

Highlights

  • Osteoarthritis (OA) is a common joint disease characterized by breakdown of articular cartilage

  • Osteoarthritis cartilage was harvested from knee joints of human patients with OA and mice induced by sectioning of the medial meniscotibial ligament 4 weeks postoperatively

  • Our result revealed that the level of heme oxygenase 1 (HO-1) expression in the cartilage tissue from both human patients and mice with OA was much higher than the control group, while there was no significant different between the groups for nuclear factor-erythroid 2-related factor 2 (Nrf2) expression (Figures 1(a)–1(d))

Read more

Summary

Introduction

Osteoarthritis (OA) is a common joint disease characterized by breakdown of articular cartilage. It is reported that about 18% of females and 10% of males aged over 60 years are affected [1]. Joint pain and stiffness decrease the quality of life for OA patients. Often joint replacement surgery is the best treatment option in late stages of the disease, when nonsurgical treatments are no longer effective. Progressive articular cartilage degradation is the hallmark of disease progression; inhibiting cartilage degradation slows or stops disease progression in OA [2]. Many potential therapeutic targets have been identified

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call